Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Nordic Nanovector ASA ( (DE:8NN) ) is now available.
Scatec Innovation AS, closely associated with Thor Medical ASA board member John Andersen, acquired 354,453 shares in Thor Medical ASA from its subsidiary, Scatec Invest IV AS, at NOK 2.388 per share. This internal transaction aims to settle balances between the parent company and its subsidiary, reflecting the last five days’ average share price.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier in the radiopharmaceutical industry, focusing on the production of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. The company uses a proprietary production process that does not require irradiation or nuclear reactors, offering a reliable, environmentally friendly, and cost-efficient supply of alpha-emitters. Thor Medical is based in Oslo, Norway, and is listed on the Oslo Stock Exchange under the ticker ‘TRMED’.
YTD Price Performance: -11.36%
Average Trading Volume: 6,429
Technical Sentiment Signal: Hold
Current Market Cap: €62.65M
Learn more about 8NN stock on TipRanks’ Stock Analysis page.